Antimicrobial Susceptibility Patterns of Bacteria Associated with Upper Respiratory Tract Infections in North and South Waziristan, Pakistan
Antimicrobial Susceptibility in URTIs in Waziristan
DOI:
https://doi.org/10.61919/jhrr.v4i3.1582Keywords:
antimicrobial resistance, upper respiratory tract infections, Staphylococcus aureus, viridans streptococci, antibiotic susceptibility, North Waziristan, South Waziristan, Kirby-BauerAbstract
Background: Upper respiratory tract infections (URTIs) are a significant cause of outpatient visits globally, with antimicrobial resistance (AMR) presenting a growing challenge to effective treatment. In Pakistan's tribal regions, limited healthcare access exacerbates this issue.
Objective: To determine the prevalence of bacterial pathogens causing URTIs and assess their antimicrobial susceptibility patterns in North and South Waziristan, Pakistan.
Methods: This cross-sectional study involved 300 throat swabs collected from outpatients between January and June 2023. Samples were inoculated on Blood, MacConkey, and Chocolate agars, followed by incubation at 37°C for 24 hours. Standard biochemical tests were used for bacterial identification, and the Kirby-Bauer disc diffusion method assessed antimicrobial susceptibility. Statistical analysis was performed using SPSS version 25.0, with p-values ≤ 0.05 considered significant.
Results: Pathogens were isolated in 93% of samples, with Staphylococcus aureus (40.2%), viridans group streptococci (35.7%), and Streptococcus pyogenes (17.1%) being the most common. Resistance was highest in viridans group streptococci (33.7% to tazobactam) and lowest in Streptococcus pyogenes (26.3%).
Conclusion: The high rates of resistance, particularly in viridans group streptococci, highlight the need for targeted interventions to mitigate AMR in this region.
Downloads
References
a
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Syed Sohail Ahmad, Laraib Abid, Arooba Khalid

This work is licensed under a Creative Commons Attribution 4.0 International License.
Public Licensing Terms
This work is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). Under this license:
- You are free to share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material) for any purpose, including commercial use.
- Attribution must be given to the original author(s) and source in a manner that is reasonable and does not imply endorsement.
- No additional restrictions may be applied that conflict with the terms of this license.
For more details, visit: https://creativecommons.org/licenses/by/4.0/.